nitroglycerin has been researched along with enalaprilat anhydrous in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (75.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Andersson, G; Held, P; Sigurdsson, A; Swedberg, K | 1 |
Lawson, DL; Mehta, JL; Mehta, P; Nichols, WW | 1 |
Schaaf, LJ; Tremel, LC; Vernon, KK; Wulf, BG | 1 |
Connelly, JF; Zigmont, EA | 1 |
Manyari, DE; Scott-Douglas, N; Smiseth, OA; Smith, ER; Tyberg, JV; Wang, SY | 1 |
Abdelwahab, W; Frishman, W; Landau, A | 1 |
Feldman, RD; Zarnke, KB | 1 |
Belenkie, I; Semeniuk, LM; Tyberg, JV | 1 |
Hirschl, MM; Kaff, A; Raab, H; Schreiber, W; Woisetschläger, C | 1 |
Marik, PE; Varon, J | 1 |
3 review(s) available for nitroglycerin and enalaprilat anhydrous
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Management of hypertensive urgencies and emergencies.
Topics: Administration, Oral; Antihypertensive Agents; Emergencies; Enalaprilat; Female; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Labetalol; Nicardipine; Nitroglycerin; Nitroprusside | 1995 |
Perioperative hypertension management.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Enalaprilat; Fenoldopam; Hemodynamics; Humans; Hydralazine; Hypertension; Incidence; Labetalol; Nicardipine; Nitroglycerin; Nitroprusside; Perioperative Care; Postoperative Complications; Propanolamines; Pyridines; Surgical Procedures, Operative; Vascular Resistance; Vasodilator Agents | 2008 |
3 trial(s) available for nitroglycerin and enalaprilat anhydrous
Article | Year |
---|---|
Enalaprilat in acute myocardial infarction: tolerability and effects on the renin-angiotensin system.
Topics: Aged; Blood Pressure; Enalaprilat; Female; Furosemide; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Metoprolol; Middle Aged; Myocardial Infarction; Nitroglycerin; Renin-Angiotensin System; Thrombolytic Therapy | 1991 |
Direct angiotensin converting enzyme inhibitor-mediated venodilation.
Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Dose-Response Relationship, Drug; Enalaprilat; Female; Hand; Heart Rate; Humans; Infusions, Intravenous; Male; Nitroglycerin; Norepinephrine; Statistics as Topic; Temperature; Vasodilation; Veins | 1996 |
[Sublingual nitroglycerin or intravenous enalaprilat in preclinical treatment of hypertensive patients with pulmonary edema].
Topics: Administration, Sublingual; Adult; Aged; Aged, 80 and over; Blood Pressure; Emergency Medical Services; Enalaprilat; Female; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Nitroglycerin; Oxygen; Prospective Studies; Pulmonary Edema; Treatment Outcome; Vasodilator Agents | 1999 |
6 other study(ies) available for nitroglycerin and enalaprilat anhydrous
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Captopril-induced reversal of nitroglycerin tolerance: role of sulfhydryl group vs. ACE-inhibitory activity.
Topics: Acetylcholine; Acetylcysteine; Animals; Aorta; Captopril; Cyclic GMP; Drug Tolerance; Enalaprilat; Nitroglycerin; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Vasodilation | 1991 |
Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside.
Topics: Critical Care; Dobutamine; Dopamine; Drug Combinations; Drug Incompatibility; Enalaprilat; Heparin; Hydrogen-Ion Concentration; Infusions, Intravenous; Nitroglycerin; Nitroprusside; Potassium Chloride | 1990 |
Intravenous antihypertensive agents for patients unable to take oral medications.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Enalaprilat; Furosemide; Humans; Hydralazine; Hypertension; Injections, Intravenous; Labetalol; Methyldopa; Nitroglycerin; Nitroprusside; Vasodilator Agents | 1995 |
Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin.
Topics: Animals; Dogs; Enalaprilat; Heart Failure; Hydralazine; Mesenteric Veins; Nitroglycerin; Plethysmography; Radionuclide Imaging; Splanchnic Circulation; Venous Pressure; Ventricular Dysfunction, Left; Ventricular Function, Left | 1995 |
Acute effects of toborinone on vascular capacitance and conductance in experimental heart failure.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dogs; Enalaprilat; Female; Heart Failure; Hemodynamics; Hydralazine; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Quinolones; Vascular Capacitance; Vasodilator Agents | 1998 |